Targeting Astrocytes for Treating Neurological Disorders: Carbon Monoxide and Noradrenaline-Induced Increase in Lactate

E-ISSN： 1873-4286|23|33|4969-4978

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.23, Iss.33, 2018-01, pp. : 4969-4978

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting cellular energy production in neurological disorders

By Baker Steven K Tarnopolsky Mark A

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 10, 2003-10 ,pp. : 1655-1679

Informa Healthcare

Access to resources Recommend Favorite

Targeting the endocannabinoid system in treating brain disorders

By Bahr Ben A Karanian David A Makanji Sagar S Makriyannis Alexandros

Expert Opinion on Investigational Drugs, Vol. 15, Iss. 4, 2006-04 ,pp. : 351-365

Informa Healthcare

Access to resources Recommend Favorite

Role of carbon monoxide in heme-induced vasodilation

By Kozma F. Johnson R.A. Nasjletti A.

European Journal of Pharmacology, Vol. 323, Iss. 2, 1997-04 ,pp. : 1-2

Elsevier

Access to resources Recommend Favorite

Targeting the Nef Induced Increase of HIV Infectivity

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 4, Iss. 4, 2004-12 ,pp. : 321-326

Bentham Science Publishers

Access to resources Recommend Favorite

Modulation by hydrogen peroxide of noradrenaline-induced contraction in aorta from streptozotocin-induced diabetic rat

By Kobayashi T. Kamata K.

European Journal of Pharmacology, Vol. 441, Iss. 1, 2002-04 ,pp. : 83-89

Elsevier

Access to resources Recommend Favorite